Literature DB >> 30819359

Pre-Treatment With Oral P2Y12 Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga Continues.

Davide Capodanno1, Dominick J Angiolillo2.   

Abstract

Entities:  

Keywords:  acute coronary syndrome; clopidogrel; myocardial infarction; percutaneous coronary intervention; prasugrel; pre-treatment; ticagrelor

Year:  2019        PMID： 30819359     DOI： 10.1016/j.jacc.2018.12.038

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis.

Authors:  Luke P Dawson; David Chen; Misha Dagan; Jason Bloom; Andrew Taylor; Stephen J Duffy; James Shaw; Jeffrey Lefkovits; Dion Stub
Journal:  JAMA Netw Open       Date:  2021-11-01

Review 2.  Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status.

Authors:  Akshyaya Pradhan; Aashish Tiwari; Giuseppe Caminiti; Chiara Salimei; Saverio Muscoli; Rishi Sethi; Marco Alfonso Perrone
Journal:  Int J Environ Res Public Health       Date:  2022-07-23       Impact factor: 4.614
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.